Validation of the English Adolescent Menstrual Poverty Questionnaire (aMPQ)
ISTH Academy. Lukindo M. 06/25/23; 381340; PB0264
Topic: Bleeding in Neonates & Children
CLICK HERE TO LOGIN
PREMIUM CONTENT
PREMIUM CONTENT
Access to Premium content is currently a membership benefit.
Click here to join ISTH or renew your membership.
Abstract
Discussion Forum (0)
Rate & Comment (0)
PB0264
Validation of the English Adolescent Menstrual Poverty Questionnaire (aMPQ)
Author(s): Mary Lukindo (she/her/hers) (Presenting Author) - Dalhousie University, Halifax, Nova Scotia, IWK Health Center, Halifax, Nova Scotia; Hannah Cameron (Co-Author) - Dalhousie University, Halifax, Nova Scotia; Meghan Pike (Co-Author) - Meghan Pike MD FRCPC(1). 1. Division Pediatric Hematology/Oncology, IWK Health, Department Pediatrics Dalhousie University, Halifax Nova Scotia, Canada; Mandy Bouchard (Co-Author) - Department of Pediatrics, IWK Health Center; Victoria Price (Co-Author) - Division Pediatric Hematology/Oncology, IWK Health; Department of Pediatrics, Dalhousie University
Background: Access to affordable menstrual products is an unmet need for many women. Our team recently developed and published the Adolescent Menstrual Poverty Questionnaire (aMPQ), a 25-item questionnaire that measures the impact of menstrual poverty on adolescents. The aMPQ was developed after review of previously published questionnaires on menstrual health and poverty but has not been previously validated.
Aims: The objective of our study was to validate the aMPQ as a tool to measure the impact of menstrual poverty on adolescents.
Methods: Expert physicians from the fields of pediatrics, adolescent medicine, pediatric hematology, and gynecology were invited by study authors to assess questions of the aMPQ for relevance and clarity by using a web-based survey. Participants rated the relevance and clarity of each question on a scale of 1 to 4 (1=not relevant/clear, 4=very relevant/clear), and the content validity index for each item (I-CVI) was calculated. The I-CVI was calculated by taking the percentage of respondents who selected a 3 or 4 on the relevance and clarity scales. An I-CVI of 0.78 or higher supports good content validity. The CVI average (S-CVI) was calculated by taking the mean of the I-CVIs. An S-CVI of 0.9 or higher supports content validity.
Results: Twelve physicians participated. Each aMPQ item had an I-CVI above 0.83 for both relevance and clarity and the overall S-CVI was 0.98. These values support content validity of the aMPQ. Respondents raised concern regarding the relevance of a question regarding the impact of the COVID-19 pandemic on accessibility of menstrual products, noting that this may no longer be relevant. When this question was removed from analysis, the S-CVI remained 0.98.
Conclusion(s): The aMPQ is a valid tool to measure the impact of menstrual poverty on adolescents.
.png)
.png)
Validation of the English Adolescent Menstrual Poverty Questionnaire (aMPQ)
Author(s): Mary Lukindo (she/her/hers) (Presenting Author) - Dalhousie University, Halifax, Nova Scotia, IWK Health Center, Halifax, Nova Scotia; Hannah Cameron (Co-Author) - Dalhousie University, Halifax, Nova Scotia; Meghan Pike (Co-Author) - Meghan Pike MD FRCPC(1). 1. Division Pediatric Hematology/Oncology, IWK Health, Department Pediatrics Dalhousie University, Halifax Nova Scotia, Canada; Mandy Bouchard (Co-Author) - Department of Pediatrics, IWK Health Center; Victoria Price (Co-Author) - Division Pediatric Hematology/Oncology, IWK Health; Department of Pediatrics, Dalhousie University
Background: Access to affordable menstrual products is an unmet need for many women. Our team recently developed and published the Adolescent Menstrual Poverty Questionnaire (aMPQ), a 25-item questionnaire that measures the impact of menstrual poverty on adolescents. The aMPQ was developed after review of previously published questionnaires on menstrual health and poverty but has not been previously validated.
Aims: The objective of our study was to validate the aMPQ as a tool to measure the impact of menstrual poverty on adolescents.
Methods: Expert physicians from the fields of pediatrics, adolescent medicine, pediatric hematology, and gynecology were invited by study authors to assess questions of the aMPQ for relevance and clarity by using a web-based survey. Participants rated the relevance and clarity of each question on a scale of 1 to 4 (1=not relevant/clear, 4=very relevant/clear), and the content validity index for each item (I-CVI) was calculated. The I-CVI was calculated by taking the percentage of respondents who selected a 3 or 4 on the relevance and clarity scales. An I-CVI of 0.78 or higher supports good content validity. The CVI average (S-CVI) was calculated by taking the mean of the I-CVIs. An S-CVI of 0.9 or higher supports content validity.
Results: Twelve physicians participated. Each aMPQ item had an I-CVI above 0.83 for both relevance and clarity and the overall S-CVI was 0.98. These values support content validity of the aMPQ. Respondents raised concern regarding the relevance of a question regarding the impact of the COVID-19 pandemic on accessibility of menstrual products, noting that this may no longer be relevant. When this question was removed from analysis, the S-CVI remained 0.98.
Conclusion(s): The aMPQ is a valid tool to measure the impact of menstrual poverty on adolescents.
Image
Table 1. Demographics, risk factors and treatments of CSVT in infants and children.
Image
Table 2. Outcomes of CSVT in infants and children.
PB0264
Validation of the English Adolescent Menstrual Poverty Questionnaire (aMPQ)
Author(s): Mary Lukindo (she/her/hers) (Presenting Author) - Dalhousie University, Halifax, Nova Scotia, IWK Health Center, Halifax, Nova Scotia; Hannah Cameron (Co-Author) - Dalhousie University, Halifax, Nova Scotia; Meghan Pike (Co-Author) - Meghan Pike MD FRCPC(1). 1. Division Pediatric Hematology/Oncology, IWK Health, Department Pediatrics Dalhousie University, Halifax Nova Scotia, Canada; Mandy Bouchard (Co-Author) - Department of Pediatrics, IWK Health Center; Victoria Price (Co-Author) - Division Pediatric Hematology/Oncology, IWK Health; Department of Pediatrics, Dalhousie University
Background: Access to affordable menstrual products is an unmet need for many women. Our team recently developed and published the Adolescent Menstrual Poverty Questionnaire (aMPQ), a 25-item questionnaire that measures the impact of menstrual poverty on adolescents. The aMPQ was developed after review of previously published questionnaires on menstrual health and poverty but has not been previously validated.
Aims: The objective of our study was to validate the aMPQ as a tool to measure the impact of menstrual poverty on adolescents.
Methods: Expert physicians from the fields of pediatrics, adolescent medicine, pediatric hematology, and gynecology were invited by study authors to assess questions of the aMPQ for relevance and clarity by using a web-based survey. Participants rated the relevance and clarity of each question on a scale of 1 to 4 (1=not relevant/clear, 4=very relevant/clear), and the content validity index for each item (I-CVI) was calculated. The I-CVI was calculated by taking the percentage of respondents who selected a 3 or 4 on the relevance and clarity scales. An I-CVI of 0.78 or higher supports good content validity. The CVI average (S-CVI) was calculated by taking the mean of the I-CVIs. An S-CVI of 0.9 or higher supports content validity.
Results: Twelve physicians participated. Each aMPQ item had an I-CVI above 0.83 for both relevance and clarity and the overall S-CVI was 0.98. These values support content validity of the aMPQ. Respondents raised concern regarding the relevance of a question regarding the impact of the COVID-19 pandemic on accessibility of menstrual products, noting that this may no longer be relevant. When this question was removed from analysis, the S-CVI remained 0.98.
Conclusion(s): The aMPQ is a valid tool to measure the impact of menstrual poverty on adolescents.
Validation of the English Adolescent Menstrual Poverty Questionnaire (aMPQ)
Author(s): Mary Lukindo (she/her/hers) (Presenting Author) - Dalhousie University, Halifax, Nova Scotia, IWK Health Center, Halifax, Nova Scotia; Hannah Cameron (Co-Author) - Dalhousie University, Halifax, Nova Scotia; Meghan Pike (Co-Author) - Meghan Pike MD FRCPC(1). 1. Division Pediatric Hematology/Oncology, IWK Health, Department Pediatrics Dalhousie University, Halifax Nova Scotia, Canada; Mandy Bouchard (Co-Author) - Department of Pediatrics, IWK Health Center; Victoria Price (Co-Author) - Division Pediatric Hematology/Oncology, IWK Health; Department of Pediatrics, Dalhousie University
Background: Access to affordable menstrual products is an unmet need for many women. Our team recently developed and published the Adolescent Menstrual Poverty Questionnaire (aMPQ), a 25-item questionnaire that measures the impact of menstrual poverty on adolescents. The aMPQ was developed after review of previously published questionnaires on menstrual health and poverty but has not been previously validated.
Aims: The objective of our study was to validate the aMPQ as a tool to measure the impact of menstrual poverty on adolescents.
Methods: Expert physicians from the fields of pediatrics, adolescent medicine, pediatric hematology, and gynecology were invited by study authors to assess questions of the aMPQ for relevance and clarity by using a web-based survey. Participants rated the relevance and clarity of each question on a scale of 1 to 4 (1=not relevant/clear, 4=very relevant/clear), and the content validity index for each item (I-CVI) was calculated. The I-CVI was calculated by taking the percentage of respondents who selected a 3 or 4 on the relevance and clarity scales. An I-CVI of 0.78 or higher supports good content validity. The CVI average (S-CVI) was calculated by taking the mean of the I-CVIs. An S-CVI of 0.9 or higher supports content validity.
Results: Twelve physicians participated. Each aMPQ item had an I-CVI above 0.83 for both relevance and clarity and the overall S-CVI was 0.98. These values support content validity of the aMPQ. Respondents raised concern regarding the relevance of a question regarding the impact of the COVID-19 pandemic on accessibility of menstrual products, noting that this may no longer be relevant. When this question was removed from analysis, the S-CVI remained 0.98.
Conclusion(s): The aMPQ is a valid tool to measure the impact of menstrual poverty on adolescents.
Image
Table 1. Demographics, risk factors and treatments of CSVT in infants and children.
Image
Table 2. Outcomes of CSVT in infants and children.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}